ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981

Detroit Center Formally Recognized As Comprehensive

August 4, 1978

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

NIC Grants Appeals Process Explained

April 19, 1985

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980